Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Twitter icon
Created with Sketch.
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Duke Capital
FY’24 results: record cashflows
12th Jul 2024
Apax Global Alpha
CM day: further proof of value added by Apax
10th Jul 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
99: Building a medical company without a specialist background | Clare Brenner of Myogenes
Stay up-to-date with the latest research
Sign up to our newsletter
Life Sciences research
Arix Bioscience
Life Sciences
1Q’20 portfolio update
By
Dr Martin Hall
19 May 2020
Shield Therapeutics Plc
Life Sciences
Reassuring trading update
By
Dr Martin Hall
11 May 2020
Stay up-to-date with the latest research
Sign up to our newsletter
Arix Bioscience
Life Sciences
Resetting the stage
By
Dr Martin Hall
23 Apr 2020
Diurnal Group Plc
Life Sciences
$52.5m US deal strengthens balance sheet further
By
Dr Martin Hall
30 Mar 2020
Arix Bioscience
Life Sciences
Fiscal 2019 – moving with the times
19 Mar 2020
Allergy Therapeutics plc
Life Sciences
Consistent first-half revenue growth
By
Dr Martin Hall
09 Mar 2020
Shield Therapeutics Plc
Life Sciences
March 2020 Investor Forum
By
Dr Martin Hall
06 Mar 2020
Diurnal Group Plc
Life Sciences
… and more to come (news flow)
28 Feb 2020
Arix Bioscience
Life Sciences
With high risk can come high reward
19 Feb 2020
Advanced Oncotherapy
Life Sciences
Confidence in LIGHT gaining momentum
By
Dr Martin Hall
17 Feb 2020
Tissue Regenix
Life Sciences
Restructured to satisfy product demand
06 Feb 2020
Prev
1
...
5
6
7
8
9
...
21
Next